Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences

About this trial

The purpose of this research study is to compare two different combinations of anesthetic medications to see which works the best in providing the longest lasting pain relief for total knee arthroplasty surgery. The drugs being used are liposomal bupivacaine compared to a combination of bupivacaine, clonidine, epinephrine, buprenorphine, and dexamethasone. Pain scores will be collected at different intervals during study participation.

Eligibility criteria

Qualifiers

18-80 years of age

Receiving primary total knee arthroplasty

Patients receiving a spinal anesthetic with ropivacaine and fentanyl

American Society of Anesthesiology (ASA) category 1 to 3

Disqualifiers

Revision of Total Knee Arthroplasty

Opioid use in the prior 6 months > 40 mg oxycodone equivalents per day or long-acting opioids as determined by the Prescription Drug Monitoring Program (PDMP)

Patients planned to receive general anesthesia

Patients planned to receive a spinal other than ropivacaine

Trial design

Treatments tested in this trial

  • Liposomal Bupivacaine
  • Bupivacaine, Clonidine, Epinephrine, Buprenorphine and Dexamethasone (BPV-CEBD) Combination

Treatment groups

90 Participants
are divided into 2 treatment groups